Primary adenocarcinoma of the bladder in a female patient: case report and literature review
DOI:
https://doi.org/10.48193/6xjjye81Keywords:
Adenocarcinoma, urinary bladder, hematuriaAbstract
Description: a 54-year-old woman presented to the emergency department complaining of severe pelvic pain accompanied by hematuria and a palpable, indurated hypogastric mass extending into the mesogastrium, associated with local inflammatory signs. She reported a previous external biopsy consistent with bladder adenocarcinoma; therefore, additional staging workup was performed to rule out secondary origins. Ultimately, the patient was diagnosed with primary bladder adenocarcinoma and underwent an anterior pelvic exenteration combined with bilateral ilioobturator lymphadenectomy, a Hartmann's colostomy, and a Bricker ileal conduit urinary diversion. The initial postoperative course at two months was favorable. However, due to systemic disease progression (lung metastases), a resolved perioperative episode of Takotsubo cardiomyopathy, and the patient's active refusal of the proposed palliative systemic chemotherapy (CAPOX regimen), she was referred to palliative care support, completing six months of follow-up
Relevance: it is important to have evidence-based studies with similar cases that allow us to better address this pathology. Therefore, this case report aims to contribute to the current medical literature.
Clinical implications: primary bladder adenocarcinoma represents between 0.5 % and 2.5 % of bladder tumors and is a pathology with limited evidence. A clinical case is presented to contribute evidence to the literature.
Conclusions: when a bladder mass with atypical characteristics and aggressive behavior is present, primary bladder adenocarcinoma should be considered as a differential diagnosis, allowing for timely clinically and surgically targeted treatment.
References
1. Ivanov A, Antonov P, Zapryanov M, Uchikov P, Belovezhdov V. Primary signet-ring cell adenocarcinoma of the bladder-A case report and review of literature. Urology Case Reports. 2022;42: 102022. https://doi.org/10.1016/j.eucr.2022.102022.
2. Ghewade P, Shukla S, Vagha S, Kalode SS, Gadkari P. Primary Adenocarcinoma of the Urinary Bladder: A Case Report on a Rare Malignancy. Cureus. 2024;16(8): e66269. https://doi.org/10.7759/cureus.66269.
3. Santa F, Akgul M, Tannous E, Pacheco RR, Lightle AR, Mohanty SK, et al. Primary adenocarcinoma of the urinary tract and its precursors: Diagnostic criteria and classification. Human Pathology. 2025;155: 105734. https://doi.org/10.1016/j.humpath.2025.105734.
4. Uhlig A, Behnes CL, Strauss A, Trojan L, Uhlig J, Leitsmann C. Primary bladder adenocarcinoma: Case report with long-term follow-up. Urology Case Reports. 2018;18: 64–66. https://doi.org/10.1016/j.eucr.2018.02.006.
5. Natale C, Leinwand GZ, Chiang J, Silberstein JL, Krane LS. Reviewing the Demographic, Prognostic, and Treatment Factors of Primary Adenocarcinoma of the Bladder: A SEER Population-based Study. Clinical Genitourinary Cancer. 2019;17(5): 380–388. https://doi.org/10.1016/j.clgc.2019.06.010.
6. Valerio M, Lhermitte B, Bauer J, Jichlinski P. Metastatic primary adenocarcinoma of the bladder in a twenty-five years old woman. Rare Tumors. 2011;3(1): e9. https://doi.org/10.4081/rt.2011.e9.
7. Zhong M, Gersbach E, Rohan SM, Yang XJ. Primary Adenocarcinoma of the Urinary Bladder: Differential Diagnosis and Clinical Relevance. Archives of Pathology & Laboratory Medicine. 2013;137(3): 371–381. https://doi.org/10.5858/arpa.2012-0076-RA.
8. Gupta S, Dharamshi JD. Adenocarcinoma of Urinary Bladder With Distant Metastasis: Huge Fungating Tumor Eroding and Ripping-Off Through Suprapubic Region: A Rare Presentation. Cureus. 2022;14(5): e24698. https://doi.org/10.7759/cureus.24698.
9. Shao G, Xu C, Liu J, Li X, Li L, Li X, et al. Clinical, Pathological, and Prognostic Analysis of Urachal Carcinoma. Urologia Internationalis. 2022;106(2): 199–208. https://doi.org/10.1159/000518028.
10. Popov H, Stoyanov GS, Ghenev P, Popov H, Stoyanov GS, Ghenev P. Intestinal-Type Adenocarcinoma of the Urinary Bladder With Coexisting Cystitis Cystica et Glandularis and Intestinal Metaplasia: A Histopathological Case Report. Cureus. 2023;15(3). https://doi.org/10.7759/cureus.36554.
11. Lu H, Zhu W, Mao W, Zu F, Wang Y, Li W, et al. Trends of incidence and prognosis of primary adenocarcinoma of the bladder. Therapeutic Advances in Urology. 2021;13: 17562872211018006. https://doi.org/10.1177/17562872211018006.
12. Chang SS, Bochner BH, Chou R, Dreicer R, Kamat AM, Lerner SP, et al. Tratamiento del Cáncer de Vejiga Músculo Invasivo y No Metastásico: Guía de AUA/ASCO/ASTRO/SUO. American Urological Association Education and Research Linthicum, MD, USA; 2019.
13. García García L, Ballesta B, Rodríguez Talavera J, Morales Orribo N, Carrión A. Urachal Pathology: Review of Cases. Urologia Internationalis. 2021;106(2): 195–198. https://doi.org/10.1159/000515648.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Revista Mexicana de Urología

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

